News
Dr. Corey: Patients who are found to have signs of possible hepatocellular carcinoma on an ultrasound study should undergo additional imaging with either four-phase multidetector computed ...
Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC ... of this study was to evaluate the combined use of the ultrasound examination and the assessment of the patients' clinical ...
Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer ... Therefore, screening for high-risk individuals, ...
Hosted on MSN2mon
PET Imaging Falls Flat for Initial Liver Cancer StagingPET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...
2d
News Medical on MSNSerum hsa_circ_101555 as a promising biomarker for hepatocellular carcinomaHepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.
3d
News-Medical.Net on MSNMursla Bio receives FDA breakthrough device designation for EvoLiver testMursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...
Researchers sought to test the performance of a deep learning model system using longitudinal magnetic resonance imaging (MRI) in predicting early recurrence in patients with hepatocellular carcinoma.
EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation from the FDA.
LIVER cancer is the fourth most common cancer in Malaysia and also the fourth leading cause of cancer-related deaths.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results